三木 義男 | 癌研ゲノムセンター

スポンサーリンク

概要

• 三木 義男の詳細を見る
• 同名の論文著者
• 癌研ゲノムセンターの論文著者

関連著者

• Kasumi Fujio

  Department of Surgery and Pathology, Cancer Institute Hospital

• Sakamoto Goi

  Department of Surgery and Pathology, Cancer Institute Hospital

• Emi Mitsuru

  Department of Molecular Biology, Institute of Gerontology, Nippon Medical School

• NAOE Tomoki

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

• 三木 義男

  癌研究会ゲノムセンター

• MIKI Yoshio

  Department of Genetic Diagnosis, the Cancer Institute Hospital of JFCR

• OHNO Ryuzo

  Aichi Cancer Center

• 加藤 洋

  癌研有明病院病理

• MIYAZAKI Yasushi

  Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit

• 加藤 洋

  癌研究会附属病院病理部

• 下地 尚

  癌研究会ゲノムセンター

• 加藤 洋

  癌研究所病理部

• YAGASAKI Fumiharu

  Department of Hematology, Saitama Medical University Hospital

• 宮田 敏

  癌研有明病院ゲノムセンター

• 新井 正美

  癌研究所遺伝子診断研究部

• 関 誠

  癌研有明病院消化器外科

• OKUMURA Hirokazu

  Department of Hematology, Kanazawa University Graduate School of Medical Science

• Morishita Yasuo

  The Second Department Of Surgery Kagoshima University School Of Medicine

• 山本 順司

  癌研有明病院消化器外科

• 野田 哲生

  癌研究会ゲノムセンター

• 山本 順司

  防衛医科大学校防衛医学研究センター 外傷研究部門

• 山口 俊晴

  癌研有明病院消化器外科

• 山口 俊晴

  癌研有明病院

• 上野 雅資

  癌研有明病院消化器外科

• IMANISHI Daisuke

  Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit

• OHTAKE Shigeki

  Department of Hematology, Kanazawa University Graduate School of Medical Science

• MIYAWAKI Shuichi

  Division of Hematology, Saiseikai Maebashi Hospital

• MATSUDA Shin

  Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation

• TAKEUCHI Jin

  Department of Hematology and Rheumatology, Nihon University School of Medicine

• ASOU Norio

  Department of Hematology, Kumamoto University School of Medicine

• Sao Hiroshi

  Department of Hematology, Meitetsu Hospital

• 大矢 雅敏

  癌研有明病院消化器外科

• 永井 正

  自治医科大学内科学講座血液学部門

• 斉浦 明夫

  癌研有明病院消化器外科

• Higashi Y

  Division Of Breast Surgery Saitama Cancer Center

• 比企 直樹

  癌研有明病院消化器外科

• 福永 哲

  癌研有明病院消化器外科

• 大山 繁和

  癌研有明病院消化器外科

• 藤本 佳也

  癌研有明病院消化器外科

• 黒柳 洋弥

  癌研有明病院消化器外科

• 宮田 敏

  癌研究会ゲノムセンター

• 上野 雅資

  癌研有明病院 消化器センター 外科

• 宮田 敏

  (財)癌研究会ゲノムセンター情報解析グループ

• 松田 健司

  和歌山県立医科大学第2外科

• 奥 喜全

  和歌山県立医科大学第2外科

• 石川 雄一

  癌研究会癌研究所病理

• YOSHINO Tadashi

  Department of Pathology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutica

• 東口 崇

  和歌山県立医科大学第2外科

• 上平 憲

  長崎大学医学部附属病院検査部

• NAGAI Tadashi

  Division of Hematology, Jichi Medical University

• KISHIMOTO Yuji

  The First Department of Internal Medicine, Kansai Medical University

• TAKAHASHI Masatomo

  Division of Hematology and Oncology, Department of Internal Medicine, St. Marianna University School

• OHSHIMA Koichi

  Department of Pathology, Kurume University School of Medicine

• MITANI Kinuko

  Department of Hematology, Dokkyo University School of Medicine

• OGAWA Yoshiaki

  Department of Hematology and Oncology, Tokai University School of Medicine

• Iida Hiroatsu

  Department of Hematology, Meitetsu Hospital

• Kamiya Yoshikazu

  Department of Hematology, Meitetsu Hospital

• 佐藤 之俊

  北里大学呼吸器外科

• Kato Masahiro

  Department of Chemical Engineering, Faculty of Engineering, Kyushu University

• 武藤 徹一郎

  癌研有明病院 消化器外科

• 大柳 文義

  癌研究会研究所病理部

• ANDO Kiyoshi

  Department of Hematology/Oncology, Tokai University School of Medicine

• 太田 博俊

  癌研究会附属病院消化器外科

• 松原 敏樹

  癌研究会附属病院消化器外科

• 高橋 孝

  癌研究会附属病院消化器外科

• 石原 省

  癌研究会附属病院消化器外科

• 國土 典宏

  癌研究会附属病院外科

• 須貝 幸子

  癌研究会附属病院臨床検査第3部

• 三木 義男

  癌研究会附属病院臨床検査第3部

• 柳澤 昭夫

  癌研究会附属病院病理部

• 関 誠

  癌研究会附属病院外科

• 上野 雅資

  癌研究会附属病院外科

• 畦倉 薫

  癌研究会附属病院外科

• 國土 典宏

  東京慈恵会医科大学 外科

• 霞 富士雄

  癌研有明病院乳腺科

• 霞 富士雄

  癌研病院乳腺外科

• 霞 富士雄

  癌研究会附属病院乳腺外科

• ITO Yoshinori

  Department of Public Health, Fujita Health University School of Health Sciences

• Kawabata S

  Second Dep. Of Internal Medicine Nagasaki Univ. School Of Medicine

• Kohno S

  Second Dep. Of Internal Medicine Nagasaki Univ. Graduate School Of Biomedical Sciences Nagasaki Univ

• Kohno Shigeru

  佐世保市立総合病院

• 石川 雄一

  癌研究会癌研究所病理部

• 加藤 洋

  癌研究会癌研究所病理学

• 中川 健

  癌研究会有明病院呼吸器外科

• Takishita S

  University Of The Ryukyus

• 瀬戸 泰之

  癌研有明病院消化器外科

• 木下 博勝

  癌研有明病院病理

• 三木 義男

  癌研有明病院ゲノムセンター

• 武藤 徹一郎

  癌研究会ゲノムセンター

• 松浦 正明

  癌研究会ゲノムセンター

• 富永 敏治

  和歌山県立医科大学第2外科

• 柳澤 昭夫

  京都府立医科大学計量診断病理

• 堀田 司

  和歌山県立医科大学第2外科

• 横山 省三

  和歌山県立医科大学第2外科

• 山上 裕機

  和歌山県立医科大学第2外科

• 工藤 慶太

  癌研究会研究所病理部

• YAMASHITA Takashi

  Department of Physics, The Cancer Institute, Japanese Foundation for Cancer Research

• 石川 雄一

  癌研究会病理部

• 有井 滋樹

  東京医科歯科大学肝胆膵外科

• Honda Sumihisa

  Department of Public Health, Nagasaki University Graduate School of Biomedical Sciences

• Rokutanda Nana

  Department Of Thoracic And Visceral Organ Surgery Graduate School Of Medicine Gunma University

• Sasaki Nana

  Division Of Hematology And Oncology Department Of Medicine Kyoto Prefectural University Of Medicine

• 河野 辰幸

  東京医科歯科大学食道・胃外科

• 中村 典明

  東京医科歯科大学肝胆膵外科

• 工藤 篤

  東京医科歯科大学肝胆膵外科

• 田中 真二

  東京医科歯科大学肝胆膵外科

• 三木 義男

  癌研究会癌研究所遺伝子診断研究部

• MORITA Yasuyoshi

  Department of Hematology, Kinki University School of Medicine

• KANAMARU Akihisa

  Department of Hematology, Kinki University School of Medicine

• TANIMOTO Mitsune

  Blood Transfusion Division, Department of Internal Medicine II, Okayama University Graduate School o

• KURIYAMA Kazutaka

  Blood Immunology Laboratory, School of Health Sciences, Faculty of Medicine and University Hospital,

• KOBAYASHI Toru

  Department of Hematopoietic Pathobiology and Medical Oncology, Mie University Graduate School of Med

• IMOTO Shion

  Hyogo Prefectural Red Cross Blood Center

• OHNISHI Kazunori

  Third Department of Internal Medicine, Hamamatsu University School of Medicine

• KIYOI Hitoshi

  Department of Hematology and Oncology, Nagoya University Graduate School of Medicine

• OKADA Masaya

  Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine

• HANDA Hiroshi

  Department of Medicine and Clinical Science, Gunma University Graduate School of Medicine

• KAGEYAMA Shinichi

  Department of Hematology and Oncology, Mie University Graduate School of Medicine

• MAEDA Yasuhiro

  Department of Hematology, Kinki University School of Medicine

• OHNISHI Kazunori

  Oncology Center, Hamamatsu University School of Medicine

• GONDO Hisashi

  Department of Internal Medicine, Saga Prefectural Hospital Koseikan

• MORIUCHI Yukiyoshi

  Department of Hematology, Sasebo City General Hospital

• 田中 博

  東京医科歯科大学情報医科学センター

• Tsuneizumi Michiko

  Department of Molecular Biology, Institute of Gerontology, Nippon Medical School

• Nagai Hisaki

  Department of Molecular Biology, Institute of Gerontology, Nippon Medical School

• SAKAMAKI Hisashi

  Division of Hematology, Tokyo Metropolitan Komagome Hospital

• EMI Nobuhiko

  Department of Hematology, Fujita Health University

• MIYAZAKI Yasushi

  The Department of Hematology, Atomic Bomb Disease Institute, Nagasaki University School of Medicine

• 岩井 武尚

  東京医科歯科大学血管外科

• KATO Shunichi

  Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine

• 岩井 武尚

  東京医科歯科大学血管・応用外科

• 岩井 武尚

  東京医科歯科大学 肝胆膵外科

• 岩井 武尚

  東京医科歯科大学 第1外科

• 岩井 武尚

  東京医科歯科大学 医歯学総合研究科

• 武藤 徹一郎

  癌研有明病院

• 田中 博

  東京医科歯科大学 情報医科学センター

• 大矢 雅敏

  獨協医科大学越谷病院外科

• 川井 学

  和歌山県立医科大学第二外科

• 稲澤 譲治

  東京医科歯科大学難病治療研究所

• 山本 浩史

  獨協医科大学第一外科

• 小西 文雄

  自治医科大学附属大宮医療センター外科

• 山本 浩史

  癌研究会附属病院消化器外科

• 中島 聰總

  癌研究会附属病院消化器外科

• 新井 正美

  癌研究会附属病院外科

• 高橋 かおる

  静岡県立静岡がんセンター乳腺外科

• 高橋 かおる

  癌研究会附属病院

• 千々岩 一男

  宮崎大学第一外科

• ANDO KOJI

  Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University

• 秋山 太

  癌研究会癌研究所乳腺病理部

• 蒔田 益次郎

  癌研有明病院乳腺科

• 西村 誠一郎

  癌研有明病院乳腺科

• 多田 敬一郎

  癌研有明病院乳腺科

• 坂元 吾偉

  癌研究所乳腺病理部

• 西村 誠一郎

  癌研究会附属病院乳腺外科

• 多田 敬一郎

  癌研究会附属病院乳腺外科

• 蒔田 益次郎

  癌研究会附属病院乳腺外科

• 吉本 賢隆

  癌研究会附属病院乳腺外科

• 伊藤 良則

  癌研究会附属病院化学療法科

• 佐藤 之俊

  癌研究会有明病院細胞診断部

• 宮内 栄作

  癌研究会有明病院呼吸器内科

• 宝来 威

  癌研究会有明病院呼吸器内科

• Miyazawa Keisuke

  Department of Biochemistry and Intractable Immune System Disease Research Center, Tokyo Medical Univ

• 茂櫛 薫

  東京医科歯科大学情報医科学センター

• Mahmut Yasen

  東京医科歯科大学情報医科学センター

• 伊東 浩次

  東京医科歯科大学肝胆膵外科

• Kohno Shigeru

  長崎大学 医学部第二内科

• 武藤 徹一郎

  癌研究会附属病院消化器外科

• 福里 利夫

  帝京大学医学部病理

• YAMADA Yasuhiko

  Department of Mathematics, Faculty of Science, Kobe University

• Suzuki Tatsuya

  Department Of Obstetrics And Gynecology School Of Medicine Jichi Medical University

• 石川 雄一

  癌研有明病院病理

• 下地 尚

  癌研有明病院ゲノムセンター

• 野田 哲生

  癌研有明病院ゲノムセンター

• 木下 博勝

  癌研究所病理部

• 瀬戸 泰之

  癌研究会ゲノムセンター

• 大矢 雅敏

  癌研有明病院 消化器センター 外科

• 佐藤 之俊

  癌研究会有明病院呼吸器外科

• 谷 眞至

  和歌山県立医科大学第2外科

• 廣野 誠子

  和歌山県立医科大学第2外科

• 伊奈 志乃美

  和歌山県立医科大学第2外科

• 山上 裕機

  和歌山医大第2外科

• 高橋 孝

  多摩北部医療センター・内科

• 大柳 文義

  癌研究会有明病院

• 西尾 誠人

  癌研究会有明病院

• 堀池 篤

  癌研究会有明病院

• 河野 辰幸

  東京医科歯科大学外科

• 新井 正美

  癌研病・家族性腫瘍セ

• YOSHIDA Teruhiko

  Genetics Division, National Cancer Center Research Institute

• 千々岩 一男

  宮崎大学腫瘍機能制御外科学

• 伊東 浩次

  東京医科歯科大学 大学院医歯学総合研究科肝胆膵･総合外科

• 稲澤 譲治

  東京医科歯科大学難治疾患研究所

• 大瀧 慈

  厚生労働科学研究

• Mizuno Kyoichi

  Division Of Cardiology Hepatology Geriatrics And Integrated Medicine Department Of Internal Medicine

• Matsuda Koichi

  Department Of Internal Medicine Tokyo Metropolitan Komagome Hospital

• Mizuno Kyoichi

  日本医科大学 内科学

• SUZUKI Yoshihiko

  Suzuki clinic

• 伊奈 志乃美

  和歌山県立医科大学第二外科

• 瀧藤 克也

  和歌山医大第二外科

• 堀田 司

  和歌山医大第二外科

• 横山 省三

  和歌山医大第二外科

もっと見る 閉じる

著作論文

• ゲノム情報を生かした個別化医療 (特集 固形癌の最新治療--癌治療への新たな取り組み) -- (治療の新たな取り組み 個別化治療)
• Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
• Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
• Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
• P-674 大腸癌肝転移切除例のSurgical Marginについての遺伝子学的および組織学的検討
• PP-1137 大腸癌肝転移に対する外科的治療戦略 : Surgical Marginについての遺伝子学的および臨床病理学的検討
• SF-107-4 大腸sm癌のリンパ節転移と遺伝子群のマイクロアレイによる解析(第107回日本外科学会定期学術集会)
• 大腸の増殖形式(PG・NPG)と遺伝子群のマイクロアレイによる解析,悪性度についての検討
• マイクロアレイによる大腸癌の異時性肝転移の高リスク群の抽出
• SY-1-2-5 肝細胞癌の進展機構解析による新規分子標的の同定(シンポジウム1-2 消化器癌の発生機序から見た治療戦略-肝胆膵癌,第62回日本消化器外科学会定期学術総会)
• PS-095-1 n0乳癌における再発予後予測システムの検討
• SY-6-6 癌遺伝子発現パターンを用いたPaclitaxelの治療効果予知 : 局所進行乳癌に対する術前化療による解析
• 早期大腸癌の発育形態と Ras-signaling Pathway 異常(第105回日本外科学会定期学術集会)
• PS-117-2 散発性大腸癌発癌におけるhMLH1発現低下の意義
• Histological and immunophenotypic changes in 59 cases of B-cell non-Hodgkin's lymphoma after rituximab therapy
• Diffuse large B-cell lymphoma after transformation from low-grade follicular lymphoma : morphological, immunohistochemical, and FISH analyses
• Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
• A-3 インベーダ法によるSNP遺伝子型データの2変量正規混合分布に基づく分類(企画セッション:SNPデータの解析における統計的諸問題)(2003年度統計関連学会連合大会記録(日本統計学会第71回大会))
• Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
• 発がん・増殖 BRCA遺伝子機能とその機能欠損による乳癌発生機序 (乳癌--基礎と臨床の架け橋)
• 図説 最新のゲノムワイド解析技術 (特集 ゲノム研究最前線--疾患ゲノム研究の現状と展望)
• 癌と骨転移のゲノム学 (特集 骨・破壊と再生のゲノム医学)
• 遺伝性乳癌の分子遺伝学--BRCA1を中心に (癌抑制遺伝子--最新トピックス)
• SNPsと有害事象情報 (特集 分子・細胞標的治療--基礎と臨床) -- (基礎)
• がんの遺伝解析 (特集 ポストゲノム時代の医療) -- (ゲノム解析からの病態解明)
• 大腸癌表層部と先進部の発現プロファイル解析
• IS-3-4 乳がん術前化学療法の効果予測システム開発の試み(第108回日本外科会定期学術集会)
• A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene
• SF-108-2 大腸癌先進部脱分化に関与する遺伝子群の同定と機能ネットワークの構築(第107回日本外科学会定期学術集会)
• O-109 原発性肺癌切除時の開胸時胸腔内洗浄液における微量肺癌細胞の検出と細胞診の比較(肺癌と分子生物学2, 第47回日本肺癌学会総会)
• DP-009-4 包括的遺伝子発現解析による膵癌リンパ節転移予測マーカーの同定(第108回日本外科学会定期学術集会)
• Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
• Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
• Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
• Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
• Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
• Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
• A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
• P-7 原発性肺癌切除時の開胸時胸腔内洗浄液におけるCEA-mRNAの検出の意義(一般演題(ポスター) トランスレーショナルリサーチ,第48回日本肺癌学会総会)
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
• Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
• Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
• Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
• Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
• 乳がんのLarge-scale genomic study
• Monosomies 7p and 12p and FLT3 internal tandem duplication : possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution
• Allelic Losses of Loci at 3p25.1,8p22,13q12,17p13.3,and 22q13 Correlate with Postoperative Recurrence in Breast Cancer
• Successful cord blood transplantation for mycosis fungoides.
• Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
• Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
• HNPCC患者の放射線治療の安全性に関する検討(第105回日本外科学会定期学術集会)
• Histological Features of Breast Cancer, Highly Sensitive to Chemotherapy
• Identifying haplotype block structure using an ancestor-derived model
• Increased incidence of interstitial pneumonia by CHOP combined with rituximab
• Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells
• Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
• Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
• Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer
• Frequent Allelic Loss at 6q26-27 in Breast Carcinomas of the Solid-tubular Histologic Type
• Correlation of Allelic Losses and Clinicopathological Factors in Primary Breast Cancers
• Mapping of a Breast Cancer Tumor Suppressor Gene Locus to a 4-cM Interval on Chromosome 18q21
• Clinicopathological Features of Hereditary Breast Cancer
• Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray
• Tocilizumab is effective for pulmonary hypertension associated with multicentric Castleman's disease
• Identification of Rad51 alteration in patients with bilateral breast cancer
• High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
• Multiplex Mutation Screening of the BRCA1 Gene in 1000 Japanese Breast Cancers
• Infrequent Mutation of the H-Cadherin Gene on Chromosome 16q24 in Human Breast Cancers
• Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
• Bilateral Nonpalpable Breast Carcinomas in a Patient with BRCA2 Germ Line Mutation and Past History of Osteosarcoma
• Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
• 癌抑制遺伝子BRCA1/2の機能およびPARP阻害剤によるBRCA変異陽性乳癌の治療 (特集 癌治療・発癌・老化の鍵を握るDNA修復経路)
• High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
• Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors
• Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells
• Differential Regulation of Eotaxin-1/CCL11 and Eotaxin-3/CCL26 Production by the TNF-α and IL-4 Stimulated Human Lung Fibroblast(Pharmacology)
• Familial breast and ovarian cancers
• Analysis of extracellular matrix of a skin tumor from patients with juvenile hyaline fibromatosis
• Sentinel Lymph Node Biopsy Using Tin Colloid RI and Blue Dye Method
• Association of Allelic Losses at 3p25.1, 13q12, or 17p13.3 with Poor Prognosis in Breast Cancers with Lymph Node Metastasis
• Allelic Loss at 1p34-36 Predicts Poor Prognosis in Node-negative Breast Cancer
• Clinical Results of Extracorporeal Membrane Oxygenation (ECMO) Support for Acute Respiratory Failure : A Comparison of a Centrifugal Pump ECMO with a Roller Pump ECMO
• Diffuse Sclerosing Variant of Papillary Thyroid Carcinoma : A Case Report
• Two Case of Breast Cancer with Cartilaginous and Osseous Metaplasia
• Long-Term Suppression of Lymphangitic Lung Metastasis from Breast Cancer Using Biweekly Docetaxel : A Case Report
• Thyroid Carcinoma with Internal Jugular Vein Thrombus : Report of a Case
• Breast-Conserving Therapy Versus Modified Radical Mastectomy in the Treatment of Early Breast Cancer in Japan
• Tamoxifen-Failed Male Breast Cancer with a High Level of Circulating Estrogen : Report of a Case
• Recurrence of Breast Cancer Following Local Excision Alone for Ductal Carcinoma in situ
• A Case Report of Advanced Male Breast Cancer with an Objective Response to Tamoxifen Treatment
• Trends of IL-6 and IL-8 Levels in Patients with Recurrent Breast Cancer: Preliminary report
• Percutaneous ethanol injection therapy for patients with inoperable thyroid papillary cancer: a report of two cases
• Surgery for Ductal Carcinoma in situ
• Tolerability and Safety of Classic Cyclophosphamide, Methotrexate, and Fluorouracil Treatment in Japanese Patients with Early Breast Cancer
• Clinical Study on the Metastasis to the Eyes from Breast Cancer
• Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia
• 遺伝子診断の展望 (乳癌--基礎・臨床研究のアップデート) -- (臨床研究 診断 遺伝子診断)
• マイクロアレイ技術と薬剤感受性評価 (あゆみ 抗癌剤感受性試験の進歩)
• Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer
• Improved detection of axillary hot nodes in lymphoscintigraphy in breast cancer located in the upper lateral quadrant with additional projection imaging
• What is the Predictor for Invasion in Non-palpable Breast Cancer with Microcalcifications?
• Mammographic and Clinicopathological Features of Mucinous Carcinoma of the Breast
• Two Distinct Commonly Deleted Regions on Chromosome 13q Suggest Involvement of BRCA2 and Retinoblastoma Genes in Sporadic Breast Carcinomas
• Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System
• Intravascular large B cell lymphoma : proposed of the strategy for early diagnosis and treatment of patients with rapid deteriorating condition
• 単一遺伝子病とゲノム--テーマ2 遺伝性悪性腫瘍(1)家族性乳癌
• Mapping of a New Target Region of Allelic Loss to a 2-cM Interval at 22q 13.1 in Primary Breast Cancer
• Surgical Treatment with Deep Hypothermia for Thoracic Aortic Aneurysm in a Patient with Renal Transplantation
• Gastrointestinal Complications after Cardiovascular Surgery with Cardiopulmonary Bypass
• Mitral Regurgitation With an Isolated Anterior Mitral Leaflet Cleft : A Case Report
• Screening Cost for Abdominal Aortic Aneurysms : Japan-Based Estimates
• Hemodynamic and Metabolic Effects of Hypertonic Saline Infusion in Normovolemic Dogs
• Surgical Treatment for Inflammatory Abdominal Aortic Aneurysm
• Pericardiectomy to Treat Constrictive Pericarditis in a Patient with Hyperbilirubinemia : Report of a Case
• Blood Cardioplegia Recovers Myocardial Viability after Simple Cold Immersion in Long-term Heart Preservation
• The Use of Radial Artery as the Second Arterial Graft for Coronary Artery Bypass Grafting
• Solitary Skin Metastasis After Lung Cancer Resection
• Endobronchial Lipoma Accompanied with Primary Lung Cancer : Report of a Case
• Obesity and Postoperative Oxygenation after Coronary Artery Bypass Grafting
• Induction of Acute-Phase Reactive Substances During Open-Heart Surgery and Efficacy of Ulinastatin Inhibiting Cytokines and Postoperative Organ Injury
• A Clinicopathologic Study of Breast Cancer Patients during Pregnancy
• Endoscopic Classification of Intraductal Lesions and Histological Diagnosis
• Mutation Analysis of the mel-18 Gene that Shows Decreased Expression in Human Breast Cancer Cell Lines
• Allelic Loss on Chromosome 1p Is Associated with Progression and Lymph Node Metastasis of Primary Breast Carcinoma
• Potential efficacy of the oral histone deacetylase inhibitor vorinostat in a phase I trial in follicular and mantle cell lymphoma
• Genetic Diagnosis of Community-Acquired MRSA: A Multiplex Real-Time PCR Method for Staphylococcal Cassette Chromosome mec Typing and Detecting Toxin Genes
• Long-term Follow-up after Aortic Valve Replacement with a Small Aortic Prosthesis
• Successful Treatment of Subarachnoid-pleural Fistula Using Pericardial Fat Pad and Fibrin Glue after Chest Wall Resection for Lung Cancer
• Epicardial Radiofrequency Ablation on a Beating Heart : An Experimental Study
• Late-onset Chylothorax after Pulmonary Resection and Systematic Mediastinal Lymph Node Dissection for Lung Cancer
• Male Breast Cancer with Nipple Erosion : A Case Report
• Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling
• Genotyping of Single Nucleotide Polymorphisms Based on a Mathematical Model for Two-Dimensional Data
• Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
• Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
• Sudden Hemorrhage of the Breast Caused by Breast Cancer: A Case Report and Review of the Literature
• Surgical Approach for Repair of Descending Thoracic Aortic Aneurysms and Postoperative Respiratory Function
• Primary Amenorrhea Accompanied by Adrenal Adenoma : Start of Menarche Soon after Tumor Resection
• 遺伝性乳癌・卵巣癌の遺伝子診断および研究の現状 (特集 婦人科における遺伝性腫瘍の取扱いの実際)
• Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
• Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with
• Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
• Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
• IgG4-Related Disease : A Novel Lymphoproliferative Disorder Discovered and Established in Japan in the 21st Century
• Pure red cell aplasia caused by parvovirus B19 in two patients without chronic hemolysis
• Growth of the Pulmonary Arteries after Systemic-Pulmonary Shunt
• Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
• Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
• Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer
• Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer
• Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
• High-dose methotrexate with R-CHOP therapy for the treatment of patients with primary central nervous system lymphoma
• High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma
• Association analysis of the NOD2 gene with susceptibility to graft-versus-host disease in a Japanese population
• Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.
• ON THE DIAGNOSIS OF SYNCHRONOUS BILATERAL BREAST CANCER BY THERMOGRAPHY
• Abnormal collagen deposition in fibromas from patient with juvenile hyaline fibromatosis
• Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia
• Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
• Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011
• A novel clinical entity, IgG4-related disease (IgG4RD) : general concept and details
• Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma
• Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement : The Nagasaki Transplant Group experience
• Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma
• Late effect of Atomic bomb radiation on myeloid disorders : leukemia and myelodysplastic syndromes

もっと見る 閉じる

スポンサーリンク